A protected platform with many ways to grow.
Direct Components Inc. owns the intellectual property, the brands and the development pipeline. Here is how we think about value.
Why Direct Components.
A summary for discussion. Financial information is shared only in a formal briefing.
Owned IP
Issued U.S. patents and pending families held by the parent company, with the spine patent running to 2043.
Platform economics
One core material serving medical, first-response, consumer and research channels.
Staged risk
Applications advance independently, so each can be funded, partnered or licensed on its own evidence.
Experienced team
Founder-led since 1998, with clinical, IP, engineering and field advisors.
Investor materials are shared directly, under NDA.
This page does not contain an offer of securities. Qualified investors can request the corporate deck, IP summary and development plan.
Next stepTalk to the founder.
Briefings are arranged directly with leadership.